Reply to Neder, to Ogata et al., and to Graham

Surya P Bhatt^{1

2}, Arie Nakhmani^{1

3}, Spyridon Fortis⁴, Matthew J Strand⁵, Edwin K Silverman⁶, Frank C Sciurba⁷, Sandeep Bodduluri^{1

2}

Affiliations

¹ UAB Lung Imaging Lab.
² Division of Pulmonary, Allergy, and Critical Care Medicine, and.
³ Department of Electrical and Computer Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
⁴ Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Hospital, Iowa City, Iowa.
⁵ Division of Biostatistics and Bioinformatics, Office of Academic Affairs, National Jewish Health, Denver, Colorado.
⁶ Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
⁷ Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Comment

Surya P Bhatt et al. Am J Respir Crit Care Med. 2024.

. 2024 Feb 1;209(3):343-345.

doi: 10.1164/rccm.202311-2016LE.

Surya P Bhatt^{1

2}, Arie Nakhmani^{1

3}, Spyridon Fortis⁴, Matthew J Strand⁵, Edwin K Silverman⁶, Frank C Sciurba⁷, Sandeep Bodduluri^{1

2}

¹ UAB Lung Imaging Lab.
² Division of Pulmonary, Allergy, and Critical Care Medicine, and.
³ Department of Electrical and Computer Engineering, University of Alabama at Birmingham, Birmingham, Alabama.
⁴ Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa Hospital, Iowa City, Iowa.
⁵ Division of Biostatistics and Bioinformatics, Office of Academic Affairs, National Jewish Health, Denver, Colorado.
⁶ Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and.
⁷ Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

No abstract available

Figures

Novel FEV₁/FVC-based Diagnosis and Severity Classification of Chronic Obstructive Pulmonary Disease: How about FEV₁ % Predicted Basing?
Ogata H, Washio Y, Yoshida M. Ogata H, et al. Am J Respir Crit Care Med. 2024 Feb 1;209(3):340-341. doi: 10.1164/rccm.202310-1739LE. Am J Respir Crit Care Med. 2024. PMID: 38033312 Free PMC article. No abstract available.
Use FEV₁/FVC Z-Score Staging to Minimize Sex and Age Bias in Staging Chronic Obstructive Pulmonary Disease.
Graham BL. Graham BL. Am J Respir Crit Care Med. 2024 Feb 1;209(3):341-342. doi: 10.1164/rccm.202310-1761LE. Am J Respir Crit Care Med. 2024. PMID: 38033313 Free PMC article. No abstract available.
Is This Really a New START in Chronic Obstructive Pulmonary Disease?
Neder JA. Neder JA. Am J Respir Crit Care Med. 2024 Feb 1;209(3):339-340. doi: 10.1164/rccm.202309-1709LE. Am J Respir Crit Care Med. 2024. PMID: 38033314 Free PMC article. No abstract available.

1. Bhatt SP, Nakhmani A, Fortis S, Strand MJ, Silverman EK, Sciurba FC, et al. FEV1/FVC severity stages for chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2023;208:676–684. - PMC - PubMed
1. Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD. The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest . 2011;139:878–886. - PubMed
1. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. ERS Global Lung Function Initiative Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J . 2012;40:1324–1343. - PMC - PubMed
1. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J . 2022;60:2101499. - PubMed
1. Bhatt SP, Sieren JC, Dransfield MT, Washko GR, Newell JD, Jr, Stinson DS, et al. COPDGene Investigators Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax . 2014;69:409–414. - PMC - PubMed